A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas
Clinical trial NCT01877382 · COMPLETED
Trial details
- NCT number
- NCT01877382
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-11
- Primary completion
- 2020-10-08
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.